Turnstone Biologics

About:

Turnstone Biologics is a privately-held clinical stage biotech company.

Website: http://www.turnstonebio.com/

Top Investors: OrbiMed, F-Prime Capital, Takeda, Northleaf Capital Partners, Versant Ventures

Description:

Turnstone Biologics is a privately-held clinical-stage biotech company. Turnstone Biologics’ mission is to deliver breakthrough cancer immunotherapies by advancing two leading and complementary platforms targeting tumor immunity, to improve survival for people with cancer.

Total Funding Amount:

$133M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

La Jolla, California, United States

Founded Date:

2015-01-01

Contact Email:

info(AT)turnstonebio.com

Founders:

Brian Lichty, David Stojdl, John Bell

Number of Employees:

101-250

Last Funding Date:

2021-07-14

IPO Status:

Public

Industries:

© 2025 bioDAO.ai